Ernexa Therapeutics (NASDAQ:ERNA) Shares Up 5.9% – What’s Next?

Ernexa Therapeutics Inc. (NASDAQ:ERNA)’s stock price was up 5.9% during trading on Tuesday . The stock traded as high as $2.59 and last traded at $2.53. Approximately 97,979 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 192,253 shares. The stock had previously closed at $2.39.

Ernexa Therapeutics Price Performance

The stock has a market cap of $10.52 million, a P/E ratio of -0.30 and a beta of 5.55. The company’s 50 day simple moving average is $3.02 and its 200 day simple moving average is $4.08.

Institutional Trading of Ernexa Therapeutics

A hedge fund recently raised its stake in Ernexa Therapeutics stock. Geode Capital Management LLC increased its holdings in shares of Ernexa Therapeutics Inc. (NASDAQ:ERNA) by 1,159.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 257,310 shares of the company’s stock after acquiring an additional 236,875 shares during the quarter. Geode Capital Management LLC owned about 4.76% of Ernexa Therapeutics worth $76,000 as of its most recent filing with the SEC. 70.55% of the stock is owned by institutional investors.

Ernexa Therapeutics Company Profile

Eterna Therapeutics Inc, a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited.